These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1830864)

  • 1. Recovery of natural cytotoxicity after bone marrow transplantation.
    Lange A; Jazwiec B; Tomaszewska-Toporska B; Toporski J
    Immunol Invest; 1991 Apr; 20(2):207-13. PubMed ID: 1830864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion and activation of human natural killer cells as therapy for autologous transplantation.
    Miller JS; Verfaillie C; McGlave P
    Prog Clin Biol Res; 1994; 389():39-45. PubMed ID: 7700914
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation.
    Dermime S; Mavroudis D; Jiang YZ; Hensel N; Molldrem J; Barrett AJ
    Bone Marrow Transplant; 1997 May; 19(10):989-99. PubMed ID: 9169643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes.
    Voogt PJ; Falkenburg JH; Fibbe WE; Veenhof WF; Hamilton M; Van Krimpen BA; Bolhuis RL
    J Immunol; 1989 Mar; 142(5):1774-80. PubMed ID: 2521886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-versus-leukemia reactions following bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S
    Prog Clin Biol Res; 1992; 377():113-25; discussion 126-7. PubMed ID: 1438407
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural killer (NK) and T cell-associated surface marker expression following allogeneic and autologous bone marrow transplantation (BMT).
    Nagler A; Rabinowitz R; Rosengolts-Rat J; Condiotti R; Schlesinger M
    J Hematother Stem Cell Res; 2000 Feb; 9(1):63-75. PubMed ID: 10738973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells.
    Margolin KA; Wright C; Forman SJ
    Leukemia; 1997 May; 11(5):723-8. PubMed ID: 9180298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation.
    Schulze A; Schirutschke H; Oelschlägel U; Schmitz M; Füssel M; Wassmuth R; Ehninger G; Bornhäuser M; Platzbecker U
    Exp Hematol; 2008 Apr; 36(4):378-89. PubMed ID: 18261840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of immunotherapy in bone marrow transplantation for acute myeloid leukemia.
    Prentice HG; Macdonald ID; Hamon MD
    Prog Clin Biol Res; 1994; 389():239-43. PubMed ID: 7700907
    [No Abstract]   [Full Text] [Related]  

  • 10. Decrease in number of CD16(Leu 11)+CD45RA(2H4)+ cells and defective production of natural killer cytotoxic factor in childhood acute lymphoblastic leukemia.
    Yamada S; Komiyama A
    Leuk Res; 1991; 15(9):785-90. PubMed ID: 1833597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.
    Ueda M; Joshi ID; Dan M; Uberti JP; Chou TH; Sensenbrenner LL; Lum LG
    Transplantation; 1993 Aug; 56(2):351-6. PubMed ID: 8356589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ultraviolet B irradiation on human natural killer cell and lymphokine activated killer cell activity: therapeutic potential in bone marrow transplantation and tumor immunotherapy.
    Yaron I; Zakheim AR; Oluwole SF; Hardy MA
    Transplant Proc; 1995 Feb; 27(1):1379. PubMed ID: 7878918
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of natural killer cells in the treatment of chronic myeloid leukemia.
    Silla LM; Whiteside TL; Ball ED
    J Hematother; 1995 Aug; 4(4):269-79. PubMed ID: 7489141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptides spanning the fusion region of Abl/Bcr are immunogenic and sensitize CD8(+) T lymphocytes to recognize native chronic myelogenous leukemia.
    Wagner WM; Ouyang Q; Pawelec G
    Leukemia; 2002 Nov; 16(11):2341-3. PubMed ID: 12399986
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone-marrow transplantation.
    Magrath I
    Lancet; 1995 Jul; 346(8966):59-60. PubMed ID: 7603173
    [No Abstract]   [Full Text] [Related]  

  • 16. Deficit of T-cell recovery after allogeneic bone marrow transplantation in chronic myeloid leukemia patients.
    Diamond HR; Souza MH; Bouzas LF; Tabak DG; Campos MM; Câmara FP; Rumjanek VM
    Anticancer Res; 1995; 15(4):1553-60. PubMed ID: 7654044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells in peripheral blood after autologous bone marrow transplantation: a combined phenotypic and functional study.
    Jorgensen H; Hokland P; Jensen T; Basse P; Hokland M
    Nat Immun; 1995; 14(3):164-72. PubMed ID: 8832900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allogeneic bone marrow transplantation in myeloid leukemia: chemical conditioning, clinical course and results].
    Glejzer O; Sedzimirska M; Tomaszewska-Toporska B; Tomeczko J; Kołodziej J; Pacuszko T; Was A; Bocheńska J; Jaźwiec B; Klimczak A
    Acta Haematol Pol; 1992; 23(2 Suppl 1):49-59. PubMed ID: 1488872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphocyte subset reconstitution following human allogeneic bone marrow transplantation].
    Aotsuka N; Asai T; Oh H; Yoshida S
    Rinsho Ketsueki; 1991 Aug; 32(8):844-50. PubMed ID: 1834874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
    Gale RP; Horowitz MM
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.